Obesity Research Archives - LucidQuest Ventures

Obesity Update: Ascletis’ ASC30, Hanmi’s CRF2 Breakthrough, Orforglipron’s…

Obesity Update: Radella’s MD-18, Korglutide’s Oral Entry, Liraglutide Launches,…

Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic…

Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…

Obesity Update: Wegovy’s 7.2mg Bid, Rhythm’s Oral Win, TRPV1 Breakthrough &…

China’s Dual GCG/GLP-1 Breakthrough, Innogen’s 2026 Goal, Zepbound's Korea…

Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…

Obesity Advancements: Arrowhead’s RNAi Debut, Lilly’s $870M Bet, Novo’s Triple…

Obesity Advancements: Regeneron’s Triplet Breakthrough, $2B Hansoh Deal,…

Latest Obesity Updates: Zealand’s Obesity Strategy, $2.2B Novo Deal, China’s…

30% Weight Loss, Zepbound vs Wegovy & Affordable Semaglutide Deals In this…

Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…